EXPONENT, INC. vs V2X, Inc., two Consulting stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where EXPO and VVX diverge most: on implied growth (priced in), EXPO reads +23.1% and VVX reads -2.2%; on debt / equity, EXPO reads 0.00 and VVX reads 0.97. The rest of the comparable metrics sit closer together. On valuation, today's EXPO price has a different growth bar priced in than VVX (+23.1% implied for EXPO vs -2.2% for VVX); the higher figure is the steeper assumption to clear, not a better or worse stock. What EXPO's price implies is a bet that sits within the historical range (whole-company basis). What VVX's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | EXPO | VVX |
|---|---|---|
| Price | $66.86 | $90.41 |
| Market cap | $3.4B | $2.8B |
| Sector | Consulting | Consulting |
| Stage | Mature | Mature |
| Implied growth (priced in) | +23.1% | -2.2% |
| P/E | 31.2 | 32.3 |
| P/B | 9.90 | 2.58 |
| P/S | 5.56 | 0.60 |
| EV/EBITDA | 25.5 | 18.9 |
| Revenue growth | +7.8% | +9.3% |
| Operating margin | 24.9% | 3.5% |
| Net margin | 18.1% | 1.9% |
| Return on equity | 32.2% | 8.0% |
| Return on assets | 15.8% | 2.8% |
| Return on invested capital | 24.1% | 7.5% |
| FCF yield | 3.4% | 4.8% |
| Dividend yield | 1.8% | — |
| Debt / equity | 0.00 | 0.97 |
| Current ratio | 2.40 | 1.25 |
| Altman Z (solvency) | 8.57 | 2.59 |
| Piotroski F (quality) | 6 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.